A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2020; you can also visit the original URL.
The file type is
This table summarizes all the available analyses (published and unpublished data) about Gardasil's efficacy in preventing all high-risk HPV-associated CIN 2+. While the vaccine showed a near 100% efficacy in preventing CIN 2+ associated with HPV 16 and 18, the result for all high-risk HPV-associated CIN 2+ was dramatically below the 70% expected by the vaccine manufacturer.doi:10.5281/zenodo.1435031 fatcat:kplrniwil5hetevwlhu4nx7t6a